2m 2m 2m 2m 2m 2m 2m
- $9.0BMarket Cap
- 9.43%1-Year Change
- Medical DistributionIndustry
Henry Schein (HSIC)
Key Performance
More- Earnings Score: 49
- Momentum Score: 78
- True Yield: N/A
- Financial Health Score: 0
Latest Research & News
Global Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034
The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.
02/10/2026, 10:00 AM • GlobeNewswire
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.
02/05/2026, 10:00 AM • GlobeNewswire
A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment strategies.
02/04/2026, 11:00 AM • GlobeNewswire
The global sleeping bruxism treatment market is projected to grow from USD 652.14 million in 2025 to USD 1,132.09 million by 2033, expanding at a 7.18% CAGR. Growth is driven by rising awareness of sleep disorders, increasing stress levels, and demand for oral appliances and behavioral therapies. Occlusal splints and night guards dominate the market, while biofeedback therapy devices represent the fastest-growing segment. North America leads with 40% market share, while Asia Pacific is expected to grow fastest at 9.25% CAGR.
01/28/2026, 6:00 AM • GlobeNewswire
Entrepreneur William Brooke Webb Jr. alleges that Henry Schein employee secretly opened a competing lab and sabotaged his business, leading to a two-volume book exposing corruption in the Oklahoma medical laboratory industry.
11/13/2025, 11:00 AM • GlobeNewswire
Henry Schein Expands Strategic Partnership With KKR, Raises Annual Outlook
Henry Schein reported strong Q3 earnings, beating consensus estimates with $1.38 adjusted earnings per share and $3.34 billion in sales. The company expanded its strategic partnership with KKR and raised its fiscal 2025 guidance for earnings and sales.
11/04/2025, 12:56 PM • Benzinga
Henry Schein (HSIC) Q2 EPS Drops 11%
Healthcare solutions distributor Henry Schein reported Q2 2025 financial results with mixed performance, experiencing revenue growth but declining profitability due to margin pressures in dental operations and increased restructuring costs.
08/05/2025, 12:31 PM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Key Executives
- Andrea Albertini
- Mark E. Mlotek
- Michael Saul Ettinger
- Ronald N. South
- Frederick Lowery
Current Ownership Distribution
- Institutions2.3B (78.76%)
- Mutual Funds588.4M (20.03%)
- Insiders35.7M (1.22%)
- Other0 (0.00%)